Targeting RNA to treat neuromuscular disease.

Targeting RNA to treat neuromuscular disease.

The development of effective therapies for neuromuscular disorders such as Duchenne muscular dystrophy (DMD) is hampered by considerable challenges: skeletal muscle is the most abundant tissue in the body, and many neuromuscular disorders are multisystemic conditions. However, despite these barriers...

Bibliografske podrobnosti
Main Authors:	Muntoni, F, Wood, M
Format:	Journal article
Jezik:	English
Izdano:	2011

Podobne knjige/članki

RNA-targeted splice-correction therapy for neuromuscular disease.
od: Wood, M, et al.
Izdano: (2010)

Syncoilin upregulation in muscle of patients with neuromuscular disease.
od: Brown, S, et al.
Izdano: (2005)

Splicing therapy for neuromuscular disease.
od: Douglas, A, et al.
Izdano: (2013)

Syncoilin expression in neuromuscular disorders
od: Torelli, S, et al.
Izdano: (2001)

Syncoilin expression in neuromuscular disorders.
od: Howman, E, et al.
Izdano: (2001)

Establishment and application of clinical biobanks in treating neuromuscular diseases
od: Ya-wen ZHAO, et al.
Izdano: (2016-10-01)

Emerging oligonucleotide therapeutics for rare neuromuscular diseases
od: Aoki, Y, et al.
Izdano: (2021)

Editorial: Genome and transcriptome editing to understand and treat neuromuscular diseases
od: Rika Maruyama, et al.
Izdano: (2023-03-01)

RNA interference: from model organisms towards therapy for neural and neuromuscular disorders.
od: Buckingham, S, et al.
Izdano: (2004)

Clinical advances of RNA therapeutics for treatment of neurological and neuromuscular diseases
od: Anja Holm, et al.
Izdano: (2022-12-01)

Systemic delivery of MicroRNA using recombinant adeno-associated virus serotype 9 to treat neuromuscular diseases in rodents
od: Pourshafie, N, et al.
Izdano: (2018)

Emergency neuromuscular admissions are avoidable: a regional audit of unplanned hospital admissions of neuromuscular patients 2009-2011: final results and recommendations.
od: Jaffer, F, et al.
Izdano: (2013)

RNA Targeting in Inherited Neuromuscular Disorders: Novel Therapeutic Strategies to Counteract Mis-Splicing
od: Veronica Verdile, et al.
Izdano: (2021-10-01)

Subcutaneous immunoglobulin in treating inflammatory neuromuscular disorders
od: Min-Suk Yoon, et al.
Izdano: (2015-07-01)

Multiple roles of integrin-α3 at the neuromuscular junction.
od: Ross, J, et al.
Izdano: (2017)

Treating neuromuscular diseases: unveiling gene therapy breakthroughs and pioneering future applications
od: Yu-Fu Wu, et al.
Izdano: (2025-02-01)

Abdominal compartment syndrome successfully treated with neuromuscular blockade
od: Kris T Chiles, et al.
Izdano: (2011-01-01)

Diseases of the neuromuscular junction.
od: McConville, J, et al.
Izdano: (2002)

Diagnosing Neuromuscular Diseases
od: Alberto L. Dubrovsky
Izdano: (2018-08-01)

Neuromuscular Diseases and Bone
od: Giovanni Iolascon, et al.
Izdano: (2019-11-01)

Neuromuscular diseases and anesthesia
od: Antonijević Vesna, et al.
Izdano: (2018-01-01)

Role of RNA Binding Proteins with prion-like domains in muscle and neuromuscular diseases
od: Gina Picchiarelli, et al.
Izdano: (2020-03-01)

Protein defects in neuromuscular diseases
od: Vainzof M., et al.
Izdano: (2003-01-01)

Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches
od: Mariot, V, et al.
Izdano: (2017)

Neuromuscular Blockade for Cardiac Arrest Patients Treated With Targeted Temperature Management: A Systematic Review and Meta-Analysis
od: Tong Lin, et al.
Izdano: (2022-05-01)

Critical Illness Neuromuscular Disease
od: J Gordon Millichap
Izdano: (1995-02-01)

Neuromuscular disease: 2023 update
od: Marta Margeta
Izdano: (2023-02-01)

Modeling neuromuscular diseases in zebrafish
od: Jaskaran Singh, et al.
Izdano: (2022-12-01)

Neuromuscular diseases: revisiting the "overtraining"
od: Marco Orsini, et al.
Izdano: (2014-04-01)

Editorial: Imaging of Neuromuscular Diseases
od: Jordi Diaz-Manera, et al.
Izdano: (2021-12-01)

Management of patients with neuromuscular disease /
od: Bach, John R., 1950-
Izdano: (c200)

Development of a high-throughput tailored imaging method in zebrafish to understand and treat neuromuscular diseases
od: Léa Lescouzères, et al.
Izdano: (2022-09-01)

Doenças neuromusculares Neuromuscular disorders
od: Umbertina C. Reed
Izdano: (2002-08-01)

The Impact of Mitochondrial Deficiencies in Neuromuscular Diseases
od: Judith Cantó-Santos, et al.
Izdano: (2020-10-01)

Predictors of overload in parents of children with neuromuscular diseases
od: A. A. Rodríguez, et al.
Izdano: (2024-02-01)

Molecular targets for autoimmune and genetic disorders of neuromuscular transmission.
od: Vincent, A, et al.
Izdano: (2000)

Neuromuscular disease. DOK7 gene therapy benefits mouse models of diseases characterized by defects in the neuromuscular junction.
od: Arimura, S, et al.
Izdano: (2014)

RNA and glia at the Drosophila neuromuscular junction: importance for synaptic plasticity
od: Gala, DS
Izdano: (2023)

Impaired neuromuscular transmission and response to acetylcholinesterase inhibitors in centronuclear myopathies.
od: Robb, SA, et al.
Izdano: (2011)

Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches
od: Virginie Mariot, et al.
Izdano: (2017-11-01)